Skip to main content
SpringerLink
Log in

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled medications are the mainstay of pharmacological treatment of COPD, and are typically administered by handheld inhalers, such as pressurised metered-dose inhalers and dry powder inhalers, or by nebulisers. For each of the three major categories of aerosol delivery devices, several new inhalers have recently been launched, each with their own particularities, advantages and disadvantages. Consequently, broader availability of new drug–device combinations will increase prescription opportunities. Despite this, however, there is limited guidance available in published guidelines on the choice of inhalers, and still less consideration is given to elderly patients with COPD. The aim of this article is to provide a guide for healthcare professionals on device selection and factors to be considered for effective inhaled drug delivery in elderly COPD patients, including device factors (device type and complexity of use), patient factors (inspiratory capabilities, manual dexterity and hand strength, cognitive ability, co-morbidities) and considerations for healthcare professionals (proper education of patients in device use).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121s–6s.

    Article  PubMed  Google Scholar 

  2. Murray CJ. Lopez AD Alternative projections of mortality, disability by cause 1990–2020. Global Burden of Disease Study. Lancet. 1997;349:1498–504.

    Article  CAS  PubMed  Google Scholar 

  3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. GOLD. http://www.goldcopd.org. Accessed 7 May 2016.

  4. Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–76.

    Article  PubMed  Google Scholar 

  5. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335–71.

    Article  PubMed  Google Scholar 

  6. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16:249–54.

    Article  CAS  PubMed  Google Scholar 

  7. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479–94.

    Article  CAS  PubMed  Google Scholar 

  8. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604.

    Article  PubMed  Google Scholar 

  9. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med Res. 2011;105:930–8.

    Article  Google Scholar 

  10. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011;63:1–8.

    PubMed  Google Scholar 

  11. Janssens JP. Aging of the respiratory system: impact on pulmonary function tests sand adaptation to exertion. Clin Chest Med. 2005;26:469–72.

    Article  PubMed  Google Scholar 

  12. Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing. 1997;26:83–6.

    Article  CAS  PubMed  Google Scholar 

  13. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat soft mist inhaler. Int J Pharm. 2004;283:1–9.

    Article  CAS  PubMed  Google Scholar 

  14. Lavorini F, Fontana GA, Usmani OS. New inhaler devices—the good, the bad and the ugly. Respiration. 2014;88:3–15.

    Article  PubMed  Google Scholar 

  15. Leach CL. The CFC to HFA transition and its impact on pulmonary drug development. Respir Care. 2005;50:1201–8.

    PubMed  Google Scholar 

  16. Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000;45:623–35.

    CAS  PubMed  Google Scholar 

  17. Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med. 2007;356:1344–51.

    Article  CAS  PubMed  Google Scholar 

  18. Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther. 2007;20:290–303.

    Article  CAS  PubMed  Google Scholar 

  19. Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs. 2006;66:1475–83.

    Article  CAS  PubMed  Google Scholar 

  20. Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, et al. European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–31.

    Article  CAS  PubMed  Google Scholar 

  21. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1–149.

    Article  CAS  PubMed  Google Scholar 

  22. Lavorini F, Fontana GA. Targeting drugs to the lungs: effect of spacer device. Exp Opin Drug Deliv. 2009;6:91–102.

    Article  CAS  Google Scholar 

  23. Sadowski CA, Cor K, Cave A, Banh HL. Administration technique and acceptance of inhaler devices in patients with asthma and COPD. Ann Pharmacother. 2015;49:639–48.

    Article  PubMed  Google Scholar 

  24. Newman SP, Weisz A, Talaee N, Clarke S. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46:712–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Price DB, Pearce L, Powell SR, Shirley J, Sayers MK. Handling and acceptability of the Easi-breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract. 1999;53:31–6.

    CAS  PubMed  Google Scholar 

  26. Hampson NB, Mueller MP. Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest. 1994;106:462–5.

    Article  CAS  PubMed  Google Scholar 

  27. Lenny J, Innes J, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94:496–500.

    Article  Google Scholar 

  28. Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):s25–37.

    PubMed  Google Scholar 

  29. Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108:358–65.

    Article  PubMed  Google Scholar 

  30. Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21:208–13.

    Article  PubMed  Google Scholar 

  31. de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Can ‘extrafine’ dry powder aerosols improve lung deposition? Eur J Pharm Biopharm. 2015;96:143–51.

    Article  PubMed  Google Scholar 

  32. Pavkov R, Mueller S, Fiebich K, Singh D, Stowasser F, Pignatelli G. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol G. Curr Med Res Opin. 2010;26:2527–33.

    Article  CAS  PubMed  Google Scholar 

  33. Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, et al. Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2016;29:167–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6:91–101.

    Article  CAS  PubMed  Google Scholar 

  35. Grant AC, Walker R, Hamilton M, Garrill K. The ELLIPTA® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J Aerosol Med Pulm Drug Deliv. 2015;28:474–85.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lavorini F, Levy ML, Corrigan C, Crompton G, ADMIT Working Group. The ADMIT series—issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir Med. 2010;19:335–41.

    Google Scholar 

  37. Newman S. Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv. 2014;11:365–78.

    Article  CAS  PubMed  Google Scholar 

  38. O’Callaghan C, Barry PW. The science of nebulized drug delivery. Thorax. 1997;52(suppl 2):s31–44.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hess DR. Nebulizers: principles and performance. Respir Care. 2000;45:609–22.

    CAS  PubMed  Google Scholar 

  40. Boe J, Dennis JH, O’Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J. 2001;18:228–42.

    Article  CAS  PubMed  Google Scholar 

  41. Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110:498–505.

    Article  CAS  PubMed  Google Scholar 

  42. Dhand R. Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47:1406–16.

    PubMed  Google Scholar 

  43. Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev. 1999;7:385–7.

    Article  Google Scholar 

  44. Denyer J. Adaptive aerosol delivery in practice. Eur Respir Rev. 1997;7:388–9.

    Google Scholar 

  45. Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5:114–9.

    Article  CAS  PubMed  Google Scholar 

  46. Skaria S, Smaldone GC. Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv. 2010;23:173–80.

    Article  CAS  PubMed  Google Scholar 

  47. Geller DE. Comparing clinical features of nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50:1313–21.

    PubMed  Google Scholar 

  48. Balzano G, Battiloro R, Biraghi M. Effectiveness and acceptability of domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med. 2000;13:25–33.

    Article  CAS  PubMed  Google Scholar 

  49. Barta SK, Crawford A, Roberts CM. Survey of patients’ views of domiciliary nebuliser treatment for chronic lung disease. Respir Med. 2002;96:375–81.

    Article  CAS  PubMed  Google Scholar 

  50. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377:1032–45.

    Article  CAS  PubMed  Google Scholar 

  51. O’Donohue WJ, National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest. 1996;109:814–20.

    Article  PubMed  Google Scholar 

  52. Kassner F, Hodder R, Bateman ED. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease. Drugs. 2004;64:1671–82.

    Article  PubMed  Google Scholar 

  53. Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Respiratory Effectiveness Group. Integrating real-life studies in the global therapeutic research framework. Lancet. Respir Med. 2013;1:e29–30.

    Google Scholar 

  54. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;20(11):CD000011.

    Google Scholar 

  55. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–84.

    PubMed  PubMed Central  Google Scholar 

  56. Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Dahl M, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51–9.

    Article  PubMed  Google Scholar 

  57. Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275–301.

    Article  CAS  PubMed  Google Scholar 

  58. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939–43.

    Article  CAS  PubMed  Google Scholar 

  59. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Coventry PA, Fisher L, Kenning C, Bee P, Bower P. Capacity, responsibility, and motivation: a critical qualitative evaluation of patient and practitioner views about barriers to self-management in people with multimorbidity. BMC Health Serv Res. 2014;14:536.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55:68–78.

    Article  CAS  PubMed  Google Scholar 

  62. Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M, et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology. 2013;18:546–52.

    Article  PubMed  Google Scholar 

  63. Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract. 2013;1:446–54.

    Article  PubMed  Google Scholar 

  64. Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19:696–704.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Pritchard JN, Nicholls C. Emerging technologies for electronic monitoring of adherence, inhaler competence, and true adherence. J Aerosol Med Pulm Durg Deliv. 2015;28:69–81.

    Article  Google Scholar 

  66. Williamson SS, Gorman PN, Jimison HB. A mobile/web app for long distance caregivers of older adults: functional requirements and design implications from a user centered design process. AMIA Annu Symp Proc. 2014;2014:1960–9.

    PubMed  PubMed Central  Google Scholar 

  67. Boulos MN, Brewer AC, Karinmkhani C, Buller DB, Dellavalle RP. Mobile medical and health apps: state of the art, concerns, regulatory control and certification. Online J Public Health Inform. 2014;5:229.

    PubMed  PubMed Central  Google Scholar 

  68. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75:18–25.

    Article  PubMed  Google Scholar 

  69. Barros G, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health-Syst Pharm. 2011;68:1221–32.

    Article  Google Scholar 

  70. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–5.

    Article  PubMed  Google Scholar 

  71. Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev. 2013;12:263–75.

    Article  PubMed  Google Scholar 

  72. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913–22.

    Article  CAS  PubMed  Google Scholar 

  73. Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.

    Article  PubMed  Google Scholar 

  74. Armitage JM, Williams SJ. Inhaler technique in the elderly. Age Ageing. 1988;17:275–8.

    Article  CAS  PubMed  Google Scholar 

  75. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984–8.

    Article  CAS  PubMed  Google Scholar 

  76. Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in asthma and COPD guidelines. Respir Med. 2014;108:694–700.

    Article  PubMed  Google Scholar 

  77. Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27:414–8.

    Article  PubMed  Google Scholar 

  78. Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817–21.

    Article  CAS  PubMed  Google Scholar 

  79. Vinken W, Dekhuijzen R, Barnes PJ, on behalf of the ADMIT Group. The ADMIT series—issues in inhalation therapy. How to choose inhaler devices for the treatment of COPD. Prim Care Respir J. 2010;19:10–20.

    Article  Google Scholar 

  80. Lavorini F, Fontana GA. Inhaler technique and patient’s preference for dry powder inhaler devices. Expert Opin Drug Deliv. 2014;11:1–3.

    Article  CAS  PubMed  Google Scholar 

  81. Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94:496–500.

    Article  CAS  PubMed  Google Scholar 

  83. Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28:219–28.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest. 1993;104:1332–7.

    Article  CAS  PubMed  Google Scholar 

  85. Ho SF, Ms OM, Steward JA, Breay P, Burr ML. Inhaler technique in older people in the community. Age Ageing. 2004;33:185–8.

    Article  PubMed  Google Scholar 

  86. Poole PJ, Saini R, Brodie SM, Black PN. Comparison of the effects of nebulized and inhaled salbutamol on breathlessness in severe COPD. Respir Med. 2005;99:372–6.

    Article  CAS  PubMed  Google Scholar 

  87. Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest. 1989;96:1241–6.

    Article  CAS  PubMed  Google Scholar 

  88. van der Palen J, Klein JJ, Kerkhoff AH, van Herwaarden CL. Evaluation of the effectiveness of 4 different inhalers in patients with COPD. Thorax. 1995;50:1183–7.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Jones V, Fernandez C, Diggory P. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people. Age Ageing. 1999;28:481–4.

    Article  CAS  PubMed  Google Scholar 

  90. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360–74.

    PubMed  Google Scholar 

  91. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Associazione Italiana Pneumologi Ospedalieri Educational Group, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19:127–36.

    Article  PubMed  Google Scholar 

  92. Göriş S, Taşci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv. 2013;26:336–44.

    Article  PubMed  Google Scholar 

  93. Jolly GP, Mohan A, Guleria R, Poulose R, George J. Evaluation of metered dose inhaler use technique and response to educational training. Indian J Chest Dis Allied Sci. 2015;57:17–20.

    CAS  PubMed  Google Scholar 

  94. Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44:593–8.

    Article  PubMed  Google Scholar 

  95. Casset A, Meunier-Spitz M, Rebotier P, Lefèvre H, Barth C, Heitz C, et al. Asthma management and inhalation techniques among community pharmacists in 2009: a comparison with the 1999 survey. J Asthma. 2014;51:964–73.

    Article  CAS  PubMed  Google Scholar 

  96. Gemicioglu B, Borekci S, Can G. Investigation of knowledge of asthma and inhaler devices in pharmacy workers. J Asthma. 2014;51:982–8.

    Article  PubMed  Google Scholar 

  97. Basheti IA, Qunaibi EA, Hamadi SA, Reddel HK. Inhaler technique training and health-care professionals: effective long-term solution for a current problem. Respir Care. 2014;59:1716–25.

    Article  PubMed  Google Scholar 

  98. De Tratto K, Gomez C, Ryan CJ, Bracken N, Steffen A, Corbridge SJ. Nurses’ knowledge of inhaler technique in the inpatient hospital setting. Clin Nurse Spec. 2014;28:156–60.

    Article  PubMed  Google Scholar 

  99. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel’s knowledge of and ability to use inhaling devices—metered-dose inhalers, spacing chambers, and breath-actuated powder inhalers. Chest. 1994;105:111–6.

    Article  CAS  PubMed  Google Scholar 

  100. Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma. 2009;46:944–95.

    Article  PubMed  Google Scholar 

  101. Leung J, Bhutani M, Leigh R, Pelletier D, Good C, Sin DD. Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma. Can Respir J. 2015;22:266–70.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental and Clinical Medicine, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy

    Federico Lavorini, Claudia Mannini, Elisa Chellini & Giovanni A. Fontana

Authors
  1. Federico Lavorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Mannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisa Chellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni A. Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Lavorini.

Ethics declarations

The present article received no support from tobacco industry sources or pharmaceutical companies.

Conflict of interest

FL has received speaker honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla and Teva; GAF has received speaker honoraria from Edmond Pharma, Dompè, Menarini Farmaceutici and Mundipharma. CM and EC declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lavorini, F., Mannini, C., Chellini, E. et al. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices. Drugs Aging 33, 461–473 (2016). https://doi.org/10.1007/s40266-016-0377-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-016-0377-y

Keywords

Search

Navigation